ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Array Biopharma (ARRY)

Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 23 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma

Array Biopharma Opened at 8.17 and Closed at: 8.11, which is 0.49% of previous session's close. It moved within a range of 7.92 and 8.41
The session was a Bearish session with an average volume of 6764900, which is 56.31% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.

Support for tomorrow is 7.77 and resistance for tomorrow is 8.26
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 7.88, 7.66 resistance for tomorrow's hourly charts is 8.37, 8.64

10 Day SMA for Array Biopharma (ARRY) is 7.62 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Array Biopharma (ARRY) is 7.4 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Array Biopharma (ARRY) is 8.18 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 8.9 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Array Biopharma is 8.44 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Array Biopharma is at 7.4 and 200 DMA is at 8.44, while 50 DMA and 100 DMA are at 8.18 and 8.9 respectively

Array Biopharma (ARRY) moving average of 20 SMA is at 7.4 and 20 EMA is at 7.59

Array Biopharma (ARRY) moving average of 50 SMA is at 8.18 and 50 EMA is at 8.01

Array Biopharma (ARRY) moving average of 100 SMA is at 8.9 and 100 EMA is at 8.36

Array Biopharma (ARRY) moving average of 200 SMA is at 8.44 and 200 EMA is at 8.23

Array Biopharma has performed better than Penumbra Inc in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Abbvie Inc in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than 111 Inc in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Quidel Corporation in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Orasure Technologies in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Novocure in short term. Holding Array Biopharma could be a better choice for now!

Intellia Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 8.61% more returns!

Array Biopharma has performed better than Minerva Neurosciences in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Merit Medical in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Insmed Inc in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Gilead Sciences in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Geron Corporation in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Fulgent Genetics in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Cerus Corporation in short term. Holding Array Biopharma could be a better choice for now!

Autolus Therapeutics has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 6.44% more returns!

Array Biopharma has performed better than Amneal Pharmaceuticals in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma has performed better than Amgen Inc in short term. Holding Array Biopharma could be a better choice for now!

Array Biopharma Technical analysis of indicators

Price action analysis of Array Biopharma (ARRY) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Array Biopharma is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 7.67 and Array Biopharma ARRY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.

Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ARRY Experts View which covers a lot of information including buying and selling signals

ARRY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here

Chart Array Biopharma (ARRY)  Technical (Analysis) Reports Array Biopharma [

Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Array Biopharma (ARRY)  Technical (Analysis) Reports Array Biopharma [

 

Back to top